{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T09:02:49Z","timestamp":1783587769234,"version":"3.55.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["16gm0910003h0002"],"award-info":[{"award-number":["16gm0910003h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22H00474"],"award-info":[{"award-number":["22H00474"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["20K21643"],"award-info":[{"award-number":["20K21643"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24K02851"],"award-info":[{"award-number":["24K02851"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018502","name":"Kanazawa University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018502","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bbadis.2025.168023","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T21:40:13Z","timestamp":1755553213000},"page":"168023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Inhibition of ELOVL6 activity impairs mitochondrial respiratory function and inhibits tumor progression in FGFR3-mutated bladder cancer cells"],"prefix":"10.1016","volume":"1871","author":[{"given":"Erika","family":"Matsuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Hasebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Matsuzaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Motomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Sakka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Muranaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minako","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Sekiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Sone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Yahagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimi","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuya","family":"Kandori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Shimano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2025.168023_bb0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","article-title":"Cellular fatty acid metabolism and cancer","volume":"18","author":"Currie","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2025.168023_bb0010","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nrc.2016.89","article-title":"The multifaceted roles of fatty acid synthesis in cancer","volume":"16","author":"Rohrig","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2025.168023_bb0015","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0022-2275(20)30465-X","article-title":"Cloning and characterization of a mammalian fatty acyl-CoA elongase as a lipogenic enzyme regulated by SREBPs","volume":"43","author":"Matsuzaka","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2025.168023_bb0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbrc.2008.01.075","article-title":"Mouse Elovl-6 promoter is an SREBP target","volume":"368","author":"Kumadaki","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2025.168023_bb0025","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/nm1662","article-title":"Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance","volume":"13","author":"Matsuzaka","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2025.168023_bb0030","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/hep.30953","article-title":"Hepatocyte ELOVL fatty acid Elongase 6 determines ceramide acyl-chain length and hepatic insulin sensitivity in mice","volume":"71","author":"Matsuzaka","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2025.168023_bb0035","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.2337\/db16-1277","article-title":"Elovl6 deficiency improves glycemic control in diabetic db\/db mice by expanding beta-cell mass and increasing insulin secretory capacity","volume":"66","author":"Zhao","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2025.168023_bb0040","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/hep.25932","article-title":"Elovl6 promotes nonalcoholic steatohepatitis","volume":"56","author":"Matsuzaka","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2025.168023_bb0045","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/ATVBAHA.110.221663","article-title":"Macrophage Elovl6 deficiency ameliorates foam cell formation and reduces atherosclerosis in low-density lipoprotein receptor-deficient mice","volume":"31","author":"Saito","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2025.168023_bb0050","doi-asserted-by":"crossref","first-page":"12582","DOI":"10.18632\/oncotarget.7179","article-title":"Phospholipid profiling identifies acyl chain elongation as a ubiquitous trait and potential target for the treatment of lung squamous cell carcinoma","volume":"7","author":"Marien","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2025.168023_bb0055","article-title":"ELOVL6 is associated with immunosuppression in lung adenocarcinoma through bioinformatics analysis","volume":"102","author":"Chen","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bbadis.2025.168023_bb0060","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/mc.23710","article-title":"ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT\/beta-catenin pathway","volume":"63","author":"Wang","year":"2024","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bbadis.2025.168023_bb0065","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1158\/0008-5472.CAN-12-3797","article-title":"Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma","volume":"73","author":"Muir","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2025.168023_bb0070","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/cas.13529","article-title":"Stearate-to-palmitate ratio modulates endoplasmic reticulum stress and cell apoptosis in non-B non-C hepatoma cells","volume":"109","author":"Shibasaki","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbadis.2025.168023_bb0075","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1038\/s41598-018-24633-3","article-title":"Elovl6 is a negative clinical predictor for liver cancer and knockdown of Elovl6 reduces murine liver cancer progression","volume":"8","author":"Su","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2025.168023_bb0080","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/s41375-023-01842-y","article-title":"The fatty acid elongase Elovl6 is crucial for hematopoietic stem cell engraftment and leukemia propagation","volume":"37","author":"Kiyoki","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.bbadis.2025.168023_bb0085","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1182\/bloodadvances.2020002578","article-title":"The fatty acid elongase ELOVL6 regulates bortezomib resistance in multiple myeloma","volume":"5","author":"Lipchick","year":"2021","journal-title":"Blood Adv."},{"issue":"3","key":"10.1016\/j.bbadis.2025.168023_bb0090","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1124\/pr.117.014944","article-title":"Current challenges and opportunities in treating glioblastoma","volume":"70","author":"Shergalis","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbadis.2025.168023_bb0095","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1007\/s12035-018-1392-2","article-title":"An adult Drosophila glioma model for studying Pathometabolic pathways of Gliomagenesis","volume":"56","author":"Chi","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbadis.2025.168023_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadva.2023.100078","article-title":"Identification of key microRNAs regulating ELOVL6 and glioblastoma tumorigenesis","volume":"3","author":"Istiqamah","year":"2023","journal-title":"BBA Adv."},{"key":"10.1016\/j.bbadis.2025.168023_bb0105","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbadis.2025.168023_bb0110","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2025.168023_bb0115","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.bbadis.2025.168023_bb0120","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/JU.0000000000000593","article-title":"Use and validation of the AUA\/SUO risk grouping for nonmuscle invasive bladder cancer in a contemporary cohort","volume":"203","author":"Ritch","year":"2020","journal-title":"J. Urol."},{"key":"10.1016\/j.bbadis.2025.168023_bb0125","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","article-title":"Advances in bladder cancer biology and therapy","volume":"21","author":"Tran","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2025.168023_bb0130","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231192402","article-title":"Predictive biomarkers for immune checkpoint inhibitor response in urothelial cancer","volume":"15","author":"Parent","year":"2023","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.bbadis.2025.168023_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17512433.2020.1702025","article-title":"Erdafitinib for the treatment of metastatic bladder cancer","volume":"13","author":"Montazeri","year":"2020","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.168023_bb0140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0092-8674(00)00114-8","article-title":"Cell signaling by receptor tyrosine kinases","volume":"103","author":"Schlessinger","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2025.168023_bb0145","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: from development to cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2025.168023_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102530","article-title":"Role of FGFR3 in bladder cancer: treatment landscape and future challenges","volume":"115","author":"Ascione","year":"2023","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bbadis.2025.168023_bb0155","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1158\/1535-7163.MCT-12-1150","article-title":"Fibroblast growth factor receptor 3 is a rational therapeutic target in bladder cancer","volume":"12","author":"Gust","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbadis.2025.168023_bb0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/path.2207","article-title":"FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer","volume":"213","author":"Tomlinson","year":"2007","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbadis.2025.168023_bb0165","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1056\/NEJMoa1817323","article-title":"Erdafitinib in locally advanced or metastatic urothelial carcinoma","volume":"381","author":"Loriot","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2025.168023_bb0170","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1158\/0008-5472.CAN-12-1329","article-title":"FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth","volume":"72","author":"Du","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2025.168023_bb0175","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11010-018-3306-z","article-title":"Increased expression of the gene encoding stearoyl-CoA desaturase 1 in human bladder cancer","volume":"447","author":"Presler","year":"2018","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2025.168023_bb0180","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-0716-2736-5_5","article-title":"Synchronization of cultured cells to G1, S, G2, and M phases by double thymidine block","volume":"2579","author":"Wang","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbadis.2025.168023_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2017.51","article-title":"A distinct function of the retinoblastoma protein in the control of lipid composition identified by lipidomic profiling","volume":"6","author":"Muranaka","year":"2017","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bbadis.2025.168023_bb0190","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211291","article-title":"Lysophosphatidylserines derived from microbiota in Crohn\u2019s disease elicit pathological Th1 response","volume":"219","author":"Otake-Kasamoto","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2025.168023_bb0195","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2025.168023_bb0200","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrendo.2017.91","article-title":"SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology","volume":"13","author":"Shimano","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbadis.2025.168023_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.571237","article-title":"New insights into targeting membrane lipids for cancer therapy","volume":"8","author":"Preta","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbadis.2025.168023_bb0210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.ircmb.2015.10.001","article-title":"Phosphatidylethanolamine metabolism in health and disease","volume":"321","author":"Calzada","year":"2016","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.bbadis.2025.168023_bb0215","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.cmet.2024.07.024","article-title":"Mitochondrial membrane lipids in the regulation of bioenergetic flux","volume":"36","author":"Decker","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2025.168023_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23095266","article-title":"Bilayer forming phospholipids as targets for cancer therapy","volume":"23","author":"Stoica","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.168023_bb0225","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jhep.2019.11.007","article-title":"The phosphatidylethanolamine biosynthesis pathway provides a new target for cancer chemotherapy","volume":"72","author":"Guan","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2025.168023_bb0230","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1080\/15548627.2022.2025572","article-title":"Atg8-PE protein-based in vitro biochemical approaches to autophagy studies","volume":"18","author":"Huang","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.bbadis.2025.168023_bb0235","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1016\/j.cell.2024.04.037","article-title":"Mitochondria at the crossroads of health and disease","volume":"187","author":"Suomalainen","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2025.168023_bb0240","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ceb.2006.08.011","article-title":"Integrin-regulated FAK-Src signaling in normal and cancer cells","volume":"18","author":"Mitra","year":"2006","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbadis.2025.168023_bb0245","article-title":"Suppression of mitochondrial complex I influences cell metastatic properties","volume":"8","author":"He","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2025.168023_bb0250","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1093\/hmg\/ddu612","article-title":"OXPHOS dysfunction regulates integrin-beta1 modifications and enhances cell motility and migration","volume":"24","author":"Nunes","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2025.168023_bb0255","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","article-title":"Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy","volume":"25","author":"Choi","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2025.168023_bb0260","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2025.168023_bb0265","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","article-title":"Mitochondrial metabolism as a target for cancer therapy","volume":"32","author":"Vasan","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2025.168023_bb0270","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41419-024-06585-x","article-title":"A first-in-class TIMM44 blocker inhibits bladder cancer cell growth","volume":"15","author":"Zhang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2025.168023_bb0275","article-title":"Mitochondrial reprogramming by activating OXPHOS via glutamine metabolism in African American patients with bladder cancer","volume":"9","author":"Reddy","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbadis.2025.168023_bb0280","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature25171","article-title":"A metabolic function of FGFR3-TACC3 gene fusions in cancer","volume":"553","author":"Frattini","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2025.168023_bb0285","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1172\/JCI74942","article-title":"PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis","volume":"125","author":"Bueno","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2025.168023_bb0290","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1038\/s41467-023-41529-7","article-title":"Efficient intervention for pulmonary fibrosis via mitochondrial transfer promoted by mitochondrial biogenesis","volume":"14","author":"Huang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2025.168023_bb0295","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.canlet.2018.10.018","article-title":"Loss of TMEM126A promotes extracellular matrix remodeling, epithelial-to-mesenchymal transition, and breast cancer metastasis by regulating mitochondrial retrograde signaling","volume":"440-441","author":"Sun","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbadis.2025.168023_bb0300","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/carcin\/bgi242","article-title":"Oxidative phosphorylation dysfunction modulates expression of extracellular matrix--remodeling genes and invasion","volume":"27","author":"van Waveren","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbadis.2025.168023_bb0305","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.7150\/ijbs.81918","article-title":"Synergism of FAK and ROS1 inhibitors in the treatment of CDH1-deficient cancers mediated by FAK-YAP signaling","volume":"19","author":"Gao","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbadis.2025.168023_bb0310","article-title":"Targeting signaling excitability in cervical and pancreatic cancer cells through combined inhibition of FAK and PI3K","volume":"26","author":"Chen","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.168023_bb0315","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1172\/JCI67841","article-title":"Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells","volume":"123","author":"Caino","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2025.168023_bb0320","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/s41467-025-56894-8","article-title":"Targeting ELOVL6 to disrupt c-MYC driven lipid metabolism in pancreatic cancer enhances chemosensitivity","volume":"16","author":"Garcia Garcia","year":"2025","journal-title":"Nat. Commun."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925003710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925003710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T02:10:12Z","timestamp":1778551812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443925003710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":64,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0925443925003710"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.168023","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of ELOVL6 activity impairs mitochondrial respiratory function and inhibits tumor progression in FGFR3-mutated bladder cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.168023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"168023"}}